Our Litigators of the Week are Paul, Weiss, Rifkind, Wharton & Garrison partners  Andrew Gordon and Jaren Elizabeth Janghorbani  for their high-stakes win in a case that fills in a newly-uncertain area of the law: When can a company walk away from a pending merger without penalty?

Almost exactly a year ago, Paul Weiss partner Lewis Clayton won Litigator of the Week for representing Fresenius SE & Co. in a landmark case in Delaware. Clayton’s client had agreed to acquire Akorn, an American generic pharmaceutical manufacturer, for $4.75 billion, only to discover substantial evidence that Akorn was violating FDA rules and regulations.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]